Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Demyelinating Diseases of the Central Nervous System”

667 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 667 results

Not applicableLooking for participantsNCT06718920
What this trial is testing

Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment

Who this might be right for
Multiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 500
Not applicableStudy completedNCT00002270
What this trial is testing

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
University of Miami
Early research (Phase 1)Study completedNCT00657683
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 65
Not applicableUnknownNCT06264037
What this trial is testing

The Experience in Neurorehabilitation Setting: a Qualitative Study

Who this might be right for
RehabilitationNeurologic DisorderStroke+3 more
IRCCS San Camillo, Venezia, Italy 40
Not applicableActive Not RecruitingNCT04495556
What this trial is testing

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The Cleveland Clinic 420
Not applicableNo Longer AvailableNCT02084121
What this trial is testing

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Who this might be right for
Metachromatic Leukodystrophy
Talaris Therapeutics Inc.
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableEnrolling By InvitationNCT06643858
What this trial is testing

Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)

Who this might be right for
HealthyMultiple SclerosisNeuromyelitis Optica Spectrum Disorders+2 more
Beijing Tiantan Hospital 10,000
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Not applicableStudy completedNCT03121105
What this trial is testing

Pathologic-MRI Findings in Atypical IIDD

Who this might be right for
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
University Hospital, Montpellier 25
Testing effectiveness (Phase 2)Ended earlyNCT00746941
What this trial is testing

Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Biogen 37
Testing effectiveness (Phase 2)Looking for participantsNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Not applicableStudy completedNCT03570268
What this trial is testing

Preventing Falls and Participation Restrictions in Neurological Diseases

Who this might be right for
Multiple SclerosisParkinson DiseaseStroke
Fondazione Don Carlo Gnocchi Onlus 90
Not applicableStudy completedNCT03710278
What this trial is testing

The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)

Who this might be right for
MeningitisEncephalitisGuillain-Barré+3 more
Spartanburg Regional Healthcare System 5
Large-scale testing (Phase 3)Study completedNCT04788615
What this trial is testing

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 185
Post-approval studies (Phase 4)Study completedNCT01534182
What this trial is testing

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 298
Not applicableEnrolling By InvitationNCT06374264
What this trial is testing

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
MedRhythms, Inc. 30
Not applicableLooking for participantsNCT06280755
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
icometrix 7,000
Not applicableLooking for participantsNCT06941584
What this trial is testing

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Who this might be right for
AIRE Deficiency
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Load More Results